Clinical trial
A Phase I/II Trial of Cyclophosphamide, Carfilzomib, Thalidomide and Dexamethasone (CYCLONE) in Patients With Newly Diagnosed Active Multiple Myeloma
NCT01057225 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Trial of Cyclophosphamide, Carfilzomib, Thalidomide and Dexamethasone (CYCLONE) in Patients With Newly Diagnosed Active Multiple Myeloma
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- September 5, 2017
- Enrollment
- 64 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
multiple myeloma, stage i multiple myeloma, stage ii multiple myeloma, stage iii multiple myeloma